UK’s draft medical guidelines give little support to CBD or cannabis

The panel responsible for recommending which drugs England’s National Health Service (NHS) should prescribe may recommend against the organisation using cannabis-based medical products. The National Institute for Health and Care Excellence (NICE) has issued draft guidelines which say that in many cases, medical cannabis is both too expensive to be cost-effective and not well-researched enough to be recommended.


Restricted content. Do you want to read more?